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The association of Natural Killer (NK) cell deficiencies with disease susceptibility has
established a central role for NK cells in host defence. In this context, genetic approaches
have been pivotal in elucidating and characterizing the molecular mechanisms underlying
NK cell function. To this end, homozygosity mapping and linkage analysis in humans have
identified mutations that impact NK cell function and cause life-threatening diseases.
However, several critical restrictions accompany genetic studies in humans. Studying
NK cell pathophysiology in a mouse model has therefore proven a useful tool. The
relevance of the mouse model is underscored by the similarities that exist between
cell-structure-sensing receptors and the downstream signaling that leads to NK cell
activation. In this review, we provide an overview of how human and mouse quantitative
trait locis (QTLs) have facilitated the identification of genes that modulate NK cell
development, recognition, and killing of target cells.
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INTRODUCTION
Progress in the field of genomics over the last few decades has pro-
vided the scientific community with invaluable tools that aid in
the understanding of genetic diseases. These developments have
led to the identification of new techniques, which have been used
to study the genetic factors underlying many complex human
diseases such as breast cancer, prostate cancer, diabetes, Crohn’s
disease, and many more (Crawford et al., 2007; Barrett et al.,
2008; Imamura and Maeda, 2011; Gudmundsson et al., 2012).
Susceptibility to these diseases has been successfully mapped to
chromosomal loci in humans via linkage analysis or genome-
wide association studies (GWAS). Together, these have increased
our understanding of the genetic variants responsible for clinical
phenotypes enormously.
Although the techniques outlined above have had an impor-
tant impact on clinical medicine, they are not without limitations.
The most significant limitation occurs in quantitative trait loci
(QTL) linkage mapping of disease susceptibility in humans; link-
age depends on the careful analysis of segregation of genes from
one generation to the next. This requires very large families
with clinical and genetic data spanning multiple generations,
ultimately limiting the number of families that can be used.
Moreover, the resolution is that of segregating chromosomes,
which tend to be fairly large regions covering several tens of
megabases. GWAS go a long way to address these issues; these
studies depend solely on the correlation between phenotype and
a specific SNP in a population, thereby increasing resolution to
a single base pair. However, soon after its popularity peaked,
limitations in GWAS also became apparent. Firstly, despite sig-
nificant associations between genetic variants and phenotypes,
identification of causative variants (be it in promoter or cod-
ing regions) remains a major challenge. Secondly, the effect of
genetic variants on disease susceptibility may only be apparent
in certain environmental conditions. In this case, the presence of
a SNP does not necessarily confer a given phenotype, resulting in
decreased penetrance. Thirdly, population stratification is a com-
mon problem encountered in these studies; a significant SNPmay
represent a population marker rather than a disease-associated
variant. This necessitates the use of larger, more heterogeneous
populations. Fourthly, even if larger populations are used, most
complex diseases have underlying genetic variants that have low
penetrance, which limits the statistical power of these studies.
Given the intrinsic limitations associated with human mapping
studies, it is apparent that a more controlled genetic model is
necessary to compliment discoveries made in humans.
For decades non-human species have been used to model
human disease. The mouse has emerged as the most popular
mammalian model partly because 99% of mouse genes have
homologous counterparts in human. This finding underscores
the utility of mouse genetics for identifying genotype–phenotype
relationships. To this end, over 450 inbred strains of labora-
tory and wild-derived mice have been described, providing a
panel with ample genetic diversity. Moreover, recent studies have
determined that, of the 2.57 billion base pairs that make up
the mouse genome, 8.27 million SNPs discriminate the most
common laboratory mouse strains (Frazer et al., 2007). This
genetic diversity coupled to better control of environmental con-
ditions has facilitated the identification of disease-causing genes
using QTL analysis (Figure 1). Moreover, the ability to breed
large mouse families quickly has addressed both the statistical
power and study design issues encountered in human studies.
In this way, QTL mapping approaches in mice have successfully
lead to the identification of loci underlying a variety of human
traits, including body weight and growth (Corva and Medrano,
2001), obesity (Brockmann and Bevova, 2002), atherosclerosis
(Brockmann and Bevova, 2002; Wang et al., 2005), susceptibility
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FIGURE 1 | Quantitative Trait locus mapping in inbred strains.
F1 progeny are generated by crossing two phenotypically divergent strains.
F1 mice can be intercrossed to produce F2 progeny or backcrossed to the
parental strains to produce N2 progeny. All progenies are phenotyped and
genotyped using informative markers across the genome. Statistical
phenotype/genotype correlations are carried out to identify genetic loci
underlying the given phenotype.
to infections (Mayilyan, 2012), cancer (Ewart-Toland et al., 2003),
andmany aspects of innate immunity, among them Natural Killer
(NK) cells (Cook et al., 2004).
In both humans and mice, NK cells are characterized by their
natural ability to kill damaged, infected or tumorigenic cells.
This recognition of threat is mediated by a repertoir of recep-
tors expressed on the surface of NK cells (Pegram et al., 2011).
Although the composition of these receptors differs between
humans and mice, the intracellular signaling leading to NK cell
effector functions is conserved. Mouse NK cells therefore consti-
tute an appropriate model to study NK cell physiopathology.
In this review we will focus on how studying the genetics of
complex human disease in combination with linkage mapping
techniques in mouse models has enhanced our understanding
of NK cell development, recognition of target cells and cytotoxic
effector functions.
NK CELL DEVELOPMENT
The maturity and number of NK cells depends on a crucial
sequence of events which is necessary for them to elicit an effi-
cient and successful immune response. Mature NK cells differ
from immature NK cells by the expression of surface receptors
and by the strength of their cytotoxic functions. Inefficient mat-
uration usually leads to hyporesponsive cells that cannot clear
pathogens efficiently, ultimately leading to more severe infection
outcomes. Understanding the maturation process is therefore of
pivotal importance and may highlight new therapeutic targets.
Genetic studies have contributed significantly to the under-
standing of NK cell maturation in both the clinical and research
setting. One of the first human deficiencies in NK cells was
reported by Eidenschenk et al. (2006). The authors observed
low NK cell numbers in the blood of four supposedly unrelated
patients of Irish nomadic descent. Other symptoms included EBV
driven lymphoma and viral susceptibilities which seemed to be
a direct result of low NK cell activity. Given the high incidence
of inbreeding in the study population, linkage mapping seemed
an appropriate tool to dissect the genetic contribution to this
phenotype. Homozygosity mapping was conducted in 13 family
members. A single significant QTL (LOD: 4.51) linked NK defi-
ciency to a locus on chr 8 (8p12-q12.2). A common haplotype
was observed in all four patients (Eidenschenk et al., 2006).
The gene responsible for this deficiency was not found until 4
years later, when additional patients were considered in an anal-
ysis by Gineau et al. (2012). These individuals displayed similar
phenotypes and allelic profiles to the patients in the initial cohort.
Remarkably, linkage analysis using all individuals identified a sin-
gle, highly significant QTL (LOD: 6.45) localizing to the same
region on chr 8. Sequence analysis discovered a specific frame
shift mutation in MCM4, a component of the mini chromosome
maintenance complex, which is important for DNA replication
initiation and elongation. This mutation introduced a prema-
ture stop codon thereby truncating the wild-type protein (863
amino acids) to 27 amino acids. Further analysis of this mutant
protein showed that it could still bind to the rest of the mini
chromosome maintenance complex and to chromatin. However,
the complex could not control the prevention of re-replication
in normal fashion. This inefficient control led to multiple DNA
aberrations and breaks, which could be rescued by expressing
wild-type MCM4 in these cells. Interestingly, other myeloid and
lymphoid cell subpopulations were normal; only NK cells were
affected.
Concurrent with the low NK cell numbers, there was selec-
tive loss in the CD56dim (more mature) subset of NK cells as
opposed to the CD56bright (more immature) subset. Terminal dif-
ferentiation usually occurs after NK cells have achieved CD56dim
status and is characterized by the appearance of CD57, the loss
of CD94, decreased proliferation and increased cytolytic activity.
Surprisingly very few NK cells from these patients showed ter-
minal maturation, thereby stressing the importance of MCM4
in NK cell maturation. Moreover, the CD56bright subset of cells
showed spontaneous apoptosis which was rescued upon IL2
and IL15 stimulation. Their proliferation capacity, however, was
much less than control cells, even upon stimulation. Conversely,
although CD56dim cells also showed excessive spontaneous apop-
tosis, which was not rescued upon IL2 and IL15 stimulation, they
still proliferated as well as control cells. Altogether, these results
suggested that the low levels of CD56dim cells likely results due to
a failure of the CD56bright cells to proliferate due to DNA breaks
(Gineau et al., 2012).
Spontaneous defects in NK cell development have also been
observed in mice. Non-obese diabetic (NOD)mice exhibit an NK
cell deficiency characterized by a reduced ability to kill YAC-1
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target cells in vitro, likely resulting from reduced NKG2D lev-
els (Ogasawara et al., 2003). In addition, NK cells from NOD
mice have a non-typical repertoire of NK receptors (Figure 2) that
affect NK cell function and survival (Belanger et al., 2008). To
explore this trait, Suwanai et al. examined the genetic control of
NK cell rejection ofMHC-I deficient cells in NODmice compared
to B6.H-2g7 (a mouse strain carrying the NOD derived H2 locus)
(Suwanai et al., 2010). In this study, NOD and B6.H-2g7 mice had
similar NK cell numbers and maturity but the cytotoxic capacity
of B6.H-2g7 mice was 2–3-fold higher than that of NOD mice.
Linkage analysis of the F2 progeny using either NK cell num-
ber or rejection capacity as mapping traits revealed a dominant
locus on chr 8 with epistatic effects of chr1, 6, and 8. A posi-
tional cloning approach was utilized to better define the genetic
region responsible for NK cell deficiency. Subcongenic mice were
generated which narrowed the chr 8 QTL to a 2Mbp region
between 83 and 85Mbp. This locus contained 9 genes, includ-
ing the one encoding IL15. Genome-wide expression analyses in
the spleenocytes of B6.H-2g7 and NOD mice revealed that IL15
was differentially expressed. As IL15 is an important cytokine for
NK cell maturation, survival, and function (Ma et al., 2006), it
became the principal candidate in this study. The defect in IL15
expression was not NK intrinsic given that IL15 expression in
macrophages and dendritic cells was also affected. Furthermore,
supplementation of NOD mice with soluble IL15RαFc rescued
NK cell deficiency and perforin secretion, confirming that a defect
in IL15 gene expression is a major contributor to the NK cell
defects observed in NODmice.
FIGURE 2 | Ly49 and KIR haplotypes. (A) The Ly49 gene cluster is located
on chr 6 within the Natural Killer gene Complex. Schematic organization of
the Ly49 haplotype is described for the inbred mouse strains that were used
to map NK cell function by QTL. (B) The KIR gene cluster is located on
chromosome 19q13.4 within the leukocyte receptor complex. Two basic
haplotypes A and B have been defined, varying in the number of activating
KIR genes. Haplotype A is uniform in terms of gene content and is composed
of five inhibitory genes (KIR2DL1, 2DL3, 3DL1, 3DL2, and 3DL3), a single
activating gene KIR2DS4, and KIR3DL4 which may have both inhibitory and
activating capacities. B haplotypes contain a variable combination of
activating (2DS1, 2DS2, 2DS3, 2DS5, 3DS1, and 2DS4) and inhibitory genes
(KIR2DL5A/B and KIR2DL2).
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Collectively, studies in both humans and the mouse model
have been pivotal in elucidating the genes involved in NK cell
maturation and development. The human studies were crucial
in identifying a mutation which inhibits NK cells from reaching
their peakmaturity and therefore hinders their antiviral response.
The mouse studies functioned as a proof of principle, emphasiz-
ing the importance of IL15 in NK cell maturation and providing
evidence that mouse models can be efficiently used in order to
decipher inefficiencies in NK cell development.
NK CELL RECOGNITION
NK cells were first characterized by their ability to efficiently
kill cells lacking major histocompatibility complex (MHC) (Stern
et al., 1980). In vivo rejection of radiolabeled tumor cell lines
either expressing MHC-I or not (RMA and RNA/s, respectively)
suggested that the recognition of MHC molecules may constitute
an inhibitory signal in the NK—target interaction (Ljunggren
and Karre, 1985). Thus, the decision to kill depends on the equi-
librium between opposing activating and inhibitory signals that
arise from activating and inhibitory receptors expressed on the
surface of NK cells. NK cell receptors for classical MHC class I
molecules are encoded by the killer Ig-like receptor (KIR) multi-
gene family in humans and the C-type lectin-like genes family
(Ly49) in mice. These receptors are polygenic, polymorphic, and
stochastically expressed (Valiante et al., 1997; Anderson, 2006;
Brown and Scalzo, 2008). The Ly49 gene family resides within
the NKC on chr 6 and different NKC haplotypes have been
described in inbred mice (Carlyle et al., 2008; Higuchi et al., 2010)
(Figure 2A). The KIR genes are located on chr 19 and two major
classes of KIR haplotypes have been identified: Haplotype A that
is predominately inhibitory and haplotype B that contains various
combinations of activating and inhibitory KIR genes (Figure 2B).
In addition to this haplotype diversity, multiple alleles exist for
each KIR gene. Each can vary in expression level and functional
capacity. Here we will discuss how vast genetic differences in the
humanKIR andmouse Ly49 genes families have been successfully
used to dissect different NK cell responses and identify loci that
control these responses in the context of viral infections.
It has been difficult to study the direct effect of individual
KIR receptor(s) recognition of target cells on disease outcome;
the high diversity of KIRs and the lack of specific tools distin-
guishing between the different KIR alleles have hindered this
progress. Given the interaction between KIR and HLA-class I
molecules, the majority of studies are based on genetic associa-
tion of KIRs in the context of their HLA-class I ligands (for review
see Khakoo and Carrington, 2006). In acquired immune defi-
ciency syndrome (AIDS), the first genetic association described
was between HIV disease progression and HLA-B alleles. This
association was shown in a small cohort of seropositive patients
wherein a significant association between homozygosity for alle-
les that share the HLA-Bw4 epitope and the control of HIV-1
viremia was observed (Flores-Villanueva et al., 2001). Subsequent
HLA-class I typing and KIR genotyping determined that the
activating KIR allele KIR3DS1, in combination with HLA-B Bw4-
80Ile, is associated with delayed progression to AIDS (Martin
et al., 2002). Although a physical interaction between KIR3DS1
and HLA-Bw4-80I has not yet been confirmed, functional data
has shown that NK cells expressing KIR3DS1 mount a more
potent response to HIV-infected Bw4-80I CD4+ T cells (Alter
et al., 2007). Moreover, NK cells expressing KIR3DS1 were more
responsive to HLA-class I negative target cells. This responsive-
ness was more profound among individuals that coexpressed
KIR3DS1 and Bw4-80I (Long et al., 2008). These data suggest
that the activating KIR might recognize a viral component in the
context of HLA-Bw4-80I, leading to NK cytotoxic effects. This
is reminiscent of the interaction between Ly49P/H2Dk and the
viral protein mo4/gp34 during mouse cytomegalovirus (MCMV)
infection which will be further discussed below (Desrosiers et al.,
2005).
HLA-Bw4 molecules are not only ligands for KIR3DS1 but
also for the many inhibitory KIR3DL1 alleles (Gumperz et al.,
1995; Carr et al., 2005). It is interesting to note that other genetic
association studies have demonstrated that some KIR3DL1 alle-
les are associated with slower HIV-1 disease progression, when
coexpressed with Bw4-80I alleles (Martin et al., 2007). In this
case, KIR3DL1-mediated protection in the context of high expres-
sion might be the consequence of better education during NK cell
development, leading to increased NK cell functional competence
as previously described (Fernandez et al., 2005; Kim et al., 2005,
2008; Anfossi et al., 2006).
A protective effect of KIR3DS1 and HLA-Bw4 was also found
in studies examining the association of KIR/HLA and hepatitis
C virus (HCV) (Khakoo et al., 2004). Resolution of low-dose
HCV infection was associated with a weak interaction between
KIR2DL3-HLA-C1. The weak inhibitory signal may result in a
greater propensity toward activating signals, thereby leading to
improved NK cell responses and increased protection as was
shown in a mouse model of MCMV infection (Fodil-Cornu et al.,
2011). Conversely, the KIR2DL3-HLA-C1 interaction was signifi-
cantly associated with susceptibility to cerebral malaria in a case-
control study of patients from Thailand (Hirayasu et al., 2012). To
address whether natural selection due to cerebral malaria might
act on both KIR2DL3 and HLA-C1, the KIR-HLA association was
analysed in malaria patients from several worldwide populations
(Single et al., 2007; Hirayasu et al., 2012). Interestingly, in highly
endemic populations, the frequency of KIR2DL3 and HLA-C1
was significantly decreased, presumably due to a fatal interac-
tion between KIR2DL-HLA-C1 during cerebral malaria infection
(Hirayasu et al., 2012). The importance of the KIR/HLA interac-
tion for infection outcome was also highlighted in a patient whose
NK cells expressed the inhibitory receptor KIR2DL1. KIR2DL1
interacts strongly with HLA-C proteins. In this particular patient,
the interaction resulted in extreme NK cell inhibition and in
recurrent CMV infections (Gazit et al., 2004). The examples out-
lined above suggests that inhibitory NK cell interaction through
KIR or Ly49 receptors are important in determining NK cell
recognition of target cells and anti-pathological responses.
Although human studies have successfully identified genetic
associations between NK cells and clinical disease, direct evidence
supporting the role of NK cell recognition in the outcome of
infection stems from studies in the mouse model. Early studies
investigating the genetic determinism of lethal MCMV infec-
tion established that different strains of mice respond differently
to MCMV challenge (Selgrade and Osborn, 1974). Later, it was
Frontiers in Immunology | NK Cell Biology January 2013 | Volume 3 | Article 425 | 4
Moussa et al. Genetic dissection of NK cell responses
reported that the outcome of MCMV infection was dependent
both on H2 genes in the MHC (Figure 3) (Chalmer et al., 1977)
as well as on non-H-2 linked genes (Grundy et al., 1981). Non-H-
2 determinants included the Cmv1 locus in C57BL/6 mice (Scalzo
et al., 1990) and Cmv3 in MA/My (Desrosiers et al., 2005). Both
loci mapped to the NKC.
Years of breeding, physical mapping, and positional cloning
were required to definitively identify the gene underlying the
Cmv1 locus: Ly49H. Ly49H is an NK cell activating receptor
required to establish resistance to MCMV infection (Scalzo et al.,
1990, 1992; Depatie et al., 1997, 1999, 2000; Forbes et al., 1997;
Lee et al., 2001). Corroborating evidence for the pivotal role of
Ly49H was also seen from transgenic, knock-out and congenic
mouse studies (Sjolin et al., 2002; Lee et al., 2003; Cheng et al.,
2008; Fodil-Cornu et al., 2008). Functional assays determined
that the m157 glycoprotein, an MCMV viral product, was the
ligand for Ly49H (Figure 4A) (Arase et al., 2002; Voigt et al.,
2003). This was further validated by in vivo experiments demon-
strating increased virulence of an MCMV strain lacking m157
in C57BL6 mice (Bubic et al., 2004). Moreover, these studies
provided unique tools to better dissect and define NK cell spe-
cific functions. These tools were used to show the following: (1)
NK cells have a regulatory function at later times post infec-
tion and this function is sustained through m157 stimulation of
Ly49H (Lee et al., 2009), (2) in perforin knock-out mice, IL-10
production by NK cells following Ly49H stimulation confers a
survival advantage compared to Ly49H−/− mice during lethal
MCMV infection (Lee et al., 2009) (3) experienced Ly49H+NK
cells during viral infection acquire a memory phenotype which
renders them more protective than naïve NK cells (Sun et al.,
2009).
The Ly49H-m157 receptor-ligand pair remains the only exam-
ple of an NK cell activating receptor binding to a private viral pro-
tein. The genetic characterization of the Cmv3 resistance locus in
MA/MY mice revealed a distinct mechanism of MCMV-infected
cell recognition (Desrosiers et al., 2005). In these mice, Cmv3-
mediated resistance was strictly dependent on the H2 haplotype,
H2k. The generation of a panel of congenic mice and transgenic
mice confirmed the importance of both MA/My NKC and H2-
Dk in conferring MCMV resistance (Xie et al., 2010; Fodil-Cornu
et al., 2011). The recognition of MCMV-infected cells by MA/My
NK cells depended on the presence of the H2-Dk molecule
in combination with the MCMV encoded protein, M04/gp34
(Figure 4A) (Kielczewska et al., 2009). Moreover, Ly49 activating
receptors providing H2-dependent m04-dependent recognition
of MCMV-infected cells seems to be a recurrent mechanism
in different inbred strains. However, the nature of the receptor
and H2 molecule can differ. For example, activating Ly49L from
BALB/c mice can detect MCMV-infected cells in the context of
H2k and H2f haplotypes (Pyzik et al., 2011). In this case, BALB/c
mice have both NK cell and H2k-dependent control of viral
spread as compared to H2d orH2b animals. This advantage, how-
ever, is abrogated during infection with m04 MCMV. Another
example has been observed in PWK/Pas mice. NK cells from these
mice express Ly49D2 which recognizes MCMV-infected cells in
the context of H2k. The protective effect of this interaction, how-
ever, remains to be demonstrated in vivo. Altogether, these data
suggest thatMCMVprovided an important evolutionary pressure
for the diversification of activating Ly49 receptors. Moreover, they
highlighted two distinct mechanisms of MCMV recognition by
NK cells: the direct Ly49H-dependent recognition of “non-self”
product (m157), and the indirect Ly49P, L and D2-dependent
recognition of “altered self” (H2-Dk/M04).
The first study implicating NK cells in the control of
Ectromelia virus (mousepox) was reported more than 20 years
ago. In this study, NK cell depletion reverted ectromelia out-
come in resistant B6 mice (Jacoby et al., 1989). Subsequently,
several informative crosses identified four major QTLs control-
ling the outcome of lethal mousepox infection (Brownstein et al.,
1991, 1992; Brownstein and Gras, 1995; Delano and Brownstein,
FIGURE 3 | Genomic organization of the mouse MHC region in inbred
mouse strains. The H2 is located on chromosome 17 and encodes for
classical class I (Ia) and non-classical class I (Ib), class II, and class III
molecules. The MHC class Ia haplotypes of the inbred mouse strains used
for MCMV QTL mapping is shown. (S), Susceptible to MCMV; (R), Resistant
to MCMV.
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FIGURE 4 | Model depicting NK cell recognition of target cells. (A) In
the context of MCMV infection, Ly49H (in C57BL/6 mice) recognizes the
viral product M157 and Ly49P (in MA/My mice) recognizes the viral
product M04/gp34 in association with H2-Dk. (B) In the context of
poxvirus infection, NKG2E-CD94 recognizes an “altered self” or a viral
product associated with the non-classical Qa-1b molecule (NKG2E-CD94
activates NK cells in synergy with NKG2D upon NKG2D—ligand
interaction; see text). (C) In the context of xenogeneic cell recognition,
Ly49D recognizes the hamster Hm1-C4 MHC class I molecule expressed
on CHO cells.
1995). One among them, Rmp1, was linked to the NKC (Delano
and Brownstein, 1995). Studies looking to provide mechanis-
tic insight demonstrated that NK cells were important both for
the inhibition of early viral replication and to promote strong
T-cell responses (Parker et al., 2007; Fang et al., 2008). The search
for relevant activating NK receptor(s) identified NKG2D (Fang
et al., 2008). This receptor likely facilitates NK cell-dependent
killing of infected cells that express NKG2D ligands. Interestingly,
however, the blocking of NKG2D receptor induced only 50%
mortality in resistant strains of mice challenged with ectromelia.
This suggested the involvement of other receptors. Further stud-
ies have implicated the CD94-NKG2E receptors in susceptibility
to ectromelia (Fang et al., 2011) (Figure 4B). In this model,
synergistic effects of NKG2D and CD94-NKG2A are required
to confer protection against Ectromelia. The precise molecular
mechanisms, however, remain elusive.
Activating Ly49 receptors can be also involved in NK cell
lysis of certain xenogeneic cells. The original observation was
that B6 IL2–activated NK (LAK) cells or fresh isolated NK cells
could kill Chinese hamster ovary cells (CHO) more efficiently
than their BALB/c counterparts (Idris et al., 1998). The genetic
locus underlying this trait, chok, was also shown to control
tumor elimination in vivo. An Ly49D neutralizing antibody could
decrease the cytotoxic capacity of B6 mice to BALB/c levels. This
indicated that Ly49D is involved in the recognition of CHO cells
(Idris et al., 1999). Ly49D also specifically stimulated the nat-
ural killing of lymphoblast targets derived from wild-type and
several MHC-congenic rats. Killing occurred in rats possessing
the RT1lv1 and RT1l MHC haplotypes but not others (RT1c,
RT1u, RT1av1, or RT1n). Given the ability of Ly-49D to medi-
ate cytotoxicity against xenogeneic cells, it was suggested that
Ly-49D may recognize xenogeneic MHC-encoded ligands. As
expected, engraftment of RMA transfected with Hm1-C4 MHC
class I molecule from hamsters showed that Hm1-C4 is the lig-
and of Ly49D normally expressed by CHO cells (Merck et al.,
2009) (Figure 4C). The specificity of Ly49D to a xenogeneic lig-
and could be the result of an evolutionary mechanism developed
to protect the host from a viral protein expressed on infected
cells, much like Ly49H with m157. This would imply that Ly49D
activation by xenogeneic cells might have arisen due to cross
reactivity with similar viral and host molecules expressed on cell
surfaces.
Altogether, the genetic studies demonstrated that activating
receptors are implicated in the recognition of many molecular
determinants that are induced by infection or stress. Moreover,
the MCMV and ectromelia models nicely demonstrate that
viruses exert an evolutionary pressure that drives newmechanisms
of resistance to viral infections.
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NK CELL KILLING
Upon activation, NK cell effector functions include both cytotox-
icity and cytokine production. Activation of NK cells requires the
presence of pro-inflammatory cytokines, such as type I interfer-
ons (IFN), IL12, 15, 18, and 21 as well as well as the engagement
of cell surface receptors (Biron et al., 1999). The primary cyto-
toxic mechanisms used by NK cells to kill target cells consist
of perforin, a membrane disturbing protein, and granzymes, a
family of serine proteases, that together induce apoptosis (Lowin
et al., 1995). NK cells can also trigger target cell apoptosis through
members of the tumor necrosis factor (TNF) superfamily such
as the death receptor-ligands FasL and TRAIL (Smyth et al.,
2005).
The importance of perforin in NK cell cytotoxicity was
highlighted by analyzing the genetic defect underlying a special
human disorder of immune dysregulation known as familial
haemophagocytic lymphohistiocytosis (FHL). In this disease,
cytotoxic T and NK cell activity was consistently low or absent
(Perez et al., 1984; Arico et al., 1988; Eife et al., 1989; Egeler et al.,
1996). A genome-wide linkage search for the FHL locus was first
conducted in 17 families, and identified the FHL2 locus on the
proximal region of chromosome 10q21-22 (Dufourcq-Lagelouse
et al., 1999). Further studies showed that this locus encodes for
perforin and confirmed the mutation in eight unrelated patients
with FHL (Stepp et al., 1999). Functional studies demonstrated
decreased cytotoxicity and low levels or absence of perforin in
lymphocytes derived from FHL patients (Stepp et al., 1999). In
other genome-wide screens of FHL families that excluded the per-
forin mutations (FHL2 locus), two other susceptibility loci were
found. The first locus, FHL3 was linked to chr 17q25 (Feldmann
et al., 2003). Sequence analysis and protein prediction within
this region identified the UNC13D gene encoding for Munc13-4
that was found mutated in the affected patients (Feldmann et al.,
2003). Functional studies showed that lytic granules in Munc13-
4-deficient cells traffic to the cell membrane and dock, but are
incapable of fusing. This data demonstrated that Munc13-4 is
essential in priming the lytic granule for membrane fusion and
exocytosis (Feldmann et al., 2003). Further molecular analy-
sis showed that the interaction between Munc13-4 and Rab27a
[which is associated with the immune disorder Griscelli syndrome
type 2 (GS2)] is crucial for degranulation and cytotoxicity, and
that mutations inMunc13-4 abrogate this interaction (Neeft et al.,
2005; Zur Stadt et al., 2006; Menager et al., 2007; Wood et al.,
2009). Interestingly, mutations in Munc13-4 in the mouse causes
hemophagocytic lymphohistiocytosis like syndrome only upon
lymphocytic choriomeningitis virus (LCMV) infection (Crozat
et al., 2007). This observation is consistent with the hypothesis
that expression of FHL phenotype is dependent on an infectious
trigger (Fisman, 2000). The second locus, FHL4 was found in a
genome-wide homozygosity analysis in a large consanguineous
FHL kindred of Kurdish descent (Zur Stadt et al., 2005). This
QTL localized to a 10cM region of chr 6q24. Analysis of candi-
date genes within the region identified several different mutations
in the Syntaxin 11 (STX11) gene in all affected patients (Zur
Stadt et al., 2005). STX11 is a soluble N-ethylmaleimide sensitive
factor attachment protein receptor (SNARE) protein that func-
tions to facilitate Rab27a lytic granule adherence to the inside
surface of the NK cell membrane (Dabrazhynetskaya et al., 2012).
Both Munc13-4 and STX11 mutations have a very similar out-
come which is lacking the ability to secrete cytotoxic substances
like perforin and granzyme to the target cell interface. Finally,
the generation of Stx11(−/−) mice demonstrated that the require-
ment of STX11 is for NK and CD8(+) T-cell cytotoxicity as well
as for neutrophil degranulation (D’Orlando et al., 2012). The
last FHL locus, FHL5 was identified using high-resolution SNP
genotyping in eight unrelated FHL patients from consanguineous
families (in which PRF1, UNC13D, or STX11 genes were intact)
and mapped to a 1Mb region on chromosome 19p (Zur Stadt
et al., 2009). The causative gene was shown to be STXBP2 encod-
ing syntaxin binding protein 2 (Munc18-2), a protein involved
in regulation of intracellular trafficking and control of SNARE
complex (Zur Stadt et al., 2009). In another study, similar muta-
tions in Munc18-2 demonstrated that STXBP2 is required at
a late step of the secretory pathway, specifically for the release
of cytotoxic granules by binding STX11 (Figure 5) (Cote et al.,
2009).
FIGURE 5 | Genetic defects in NK cell cytotoxicity. NK cell effector
functions are triggered through activating receptors and/or cytokines.
A cascade of intracellular events will induce the biogenesis of perforin and
maturation of granzyme B that will be secreted via cytotoxic granules
leading to apoptosis of target cells via DNA fragmentation. The mutations
affecting maturation of the cytotoxic granules or their transport to the cell
membrane are shown.
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Another genetic disorder involving defects in NK cell cytolytic
activity was first described by Papillion and Lefevre in 1924.
Known as Papillion–Lefevre syndrome (PLS), it is character-
ized by palmoplantar keratosis, as well as premature loss of
deciduous and permanent teeth (Hart et al., 1998). In the
late 1990’s, the cause of this keratosis was unknown; how-
ever, it was generally believed that an epithelial defect rendered
tissues susceptible to infection, leading to excess periodontal
destruction (Preus, 1988; Soskolne et al., 1996). To address
this anomaly, Firatli et al. conducted a study involving 10
families, totalling 44 people, of which 14 were PLS patients
(Hart et al., 1998). Pedigree analysis revealed that this was
an inherited autosomal recessive disease. Homozygosity linkage
mapping was used on the PLS patients and identified a sig-
nificant peak on chr 11q14-21 (Hart et al., 1998). Using finer
mapping and haplotype reconstruction, the candidate region
was narrowed down to 4-5cM interval. A year later, a study by
Toomes et al. narrowed this region down even further to 1.2cM.
The interval contained Cathepsin C which was later shown to
be the gene responsible for PLS (Toomes et al., 1999). They
showed the cDNA sequence was composed of 7 exons and
6 introns, identical to the previously described mouse gene.
They also confirmed the protein defect in PLS patients via
functional assays (Pham et al., 1997). The same year, studies
in mice characterized the function of Cathepsin C, and found
it to be involved in the cleavage of pro-granzyme B and A
to their functional isoforms in mouse LAK cells (Figure 5)
(Pham and Ley, 1999). Interestingly, a later study by Meade
et al. found that, unlike the mouse model, PLS patient LAK cells
were normal. However, unstimulated PLS NK cells displayed
a drastic deficiency in granzyme B activity when compared to
controls (Meade et al., 2006). Moreover, western blots showed
that granzyme B in PLS patients was larger than in controls,
proving that they did not get processed to their active forms.
When cathepsin C activity was monitored, it appeared that its
activity was low in both IL2 stimulated and unstimulated PLS
NK cells. This could be due to another redundant gene that
takes over the function of cathepsin when stimulated with IL2
or that, unlike the mouse model, human NK cells did not need
cathepsin C for granzyme B processing/activity. The granzyme
B deficiency in unstimulated PLS NK cells was correlated to
their low ability to kill target cells in an independent perforin
manner. Thus, this study showed that granzyme B is present
in PLS patients, but due to a processing disorder that is inde-
pendent of cathepsin C, is inactive. Cathepsin C, however, is
probably still the causative mutation of PLS since it is also
involved in the processing of other granzymes and has been
shown in many independent mapping studies to be linked to
PLS (Toomes et al., 1999). Deciphering the genetic etiology of
PLS exemplifies how mouse studies can provide mechanistic
insight into human diseases, but should be taken with a grain
of salt.
CONCLUDING REMARKS
The mouse model has proven invaluable for the dissection of
factors that affect immune cell function. In particular, these
models have greatly advanced our understanding of NK cell
metabolism, most notably in the context of infectious disease.
They have provided insight that was otherwise inaccessible due to
the design and technological restrictions associated with human
studies. Although many of these restrictions have been addressed
with the advent of rapid and accurate next generation sequenc-
ing platforms, mouse models remain relevant. Their continued
utility is particularly evident for the study of HLA/KIR interac-
tions. The massive variation present between individuals makes
studying these nearly impossible in humans. Newly developed
humanized mice, however, can be used to dissect these inter-
actions and decipher their effect on various human conditions
(be it in response to infection or in the context of autoim-
mune disease). The relevance of humanized mice for studying
human diseases is further emphasized by the fact that some
can be infected with human pathogens such as HCMV. Aside
from humanized mice, large-scale ENU projects have identified
many genes relevant for human disease. The main advantage
to these studies is that mice usually display a strong pheno-
type upon mutation and this can be studied independently of
any genetic background effect. Although the genes identified in
ENU screens do not always generate a comparable phenotype in
humans, they often alter the function of a pathway that is com-
mon to humans. In this way, these studies remain informative
for human disease as they can provide mechanistic insight. Thus,
although new technologies have greatly enhanced our discovery
potential in the realm of genetics, the mouse model will con-
tinue to serve as an important compliment. Together they will
work to further our knowledge of genetics and its role in human
disease.
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